Shift Health co-hosted a Product Development Boot Camp with the Global HIV Vaccine Enterprise, affording participants an opportunity to discuss best practices, learn from other experts and create an enduring toolkit that will serve the HIV vaccine field and beyond.
Clinical experience and patients’ needs drive science, ensuring the flow of knowledge and innovation from ‘bench to bedside to population to bench’. This paper discusses the conditions for success for Saudi Arabia to capitalize on translational research.
We describe how business planning principles can be applied to the commercialization activities of technology transfer offices to understand the factors that influence sustainability, increase profitability and decrease dependence on external funding sources.
This paper, authored by Shift Health in collaboration with Research Canada, introduces Research Canada’s model of the FIS as a basis for understanding how Canada can fully capitalize on its health research investments.
Shift Health Principal Dr. Rami Batal and Associate Dr. Michael Julius explored these opportunities at the BIO Convention 2012 as part of an expert panel chaired by Shift Health President Dr. Ryan Wiley.
This paper illuminates the context in which healthcare markets in Asia operate such as rising demand for high-quality healthcare in the context of persistent supply gaps, a rapid increase in healthcare spending; and complexity in market dynamics, the policy landscape and investment models.